
Global accelerator SparkLabs (CEO Kim Yu-jin) announced on the 14th that it will co-host the 'AI the Future of Bio-Health Startup Forum' for bio-health startups with Dreamplus on the 30th.
This forum invites promising startup founders who are leading the innovation of K-bio through the convergence of AI and the bio-health industry, and discusses the latest trends, challenges, and future vision of the bio industry in depth based on real-life cases.
Speakers include ▲ Weichen CEO Kim Kyung-nam, who is developing the AI endoscopic medical device 'WAYMED Endo' and supplying it to global regions including Vietnam, Thailand, and the Middle East, and ▲ Innogenix CEO Lee Hye-young, who is developing the blood-based colon cancer early diagnosis kit 'ONCOCHECK' and the infectious disease tsutsugamushi disease rapid diagnosis kit, who will share their founding backgrounds, technology development process, and global market entry strategies.
In addition, SparkLabs Co-CEO Ho-min Kim, who is in charge of hosting the forum, will introduce investment trends and practical know-how for bio startups, focusing on follow-up investment attraction cases of SparkLabs portfolio companies.
The event will be held at the event hall on the first basement floor of Dream Plus Gangnam, Seocho-gu, Seoul. Anyone who is a founder (or prospective founder) or an associate of a related company in the bio and healthcare fields can attend for free by pre-registering through the SparkLabs official website.
SparkLabs CEO Kim Yu-jin said, “As we enter an era where AI can predict and diagnose diseases early, the convergence of bio and cutting-edge technology is rapidly changing the new paradigm of the healthcare industry.” He added, “I hope this forum will provide entrepreneurs with practical insights and serve as an opportunity to expand the possibilities for cooperation between industries.”
Meanwhile, SparkLabs launched a bio-specialized subsidiary, 'SparkBioLabs (formerly SparkBio),' in 2023, and in 2024, opened 'MediopenLab,' a shared laboratory platform for fostering bio and health tech startups, together with the Korea Health Management Association, the largest medical institution specializing in health checkups in Korea. In addition, last year, it collaborated with Yonsei University Biohealth Technology Holdings, Seoul National University Hospital Biomedical Research Institute, and Partners Investment to provide comprehensive support for the growth of the bio industry, covering everything from technology commercialization to investment linkage.
- See more related articles
You must be logged in to post a comment.